CA1001073A - Anaesthetic compositions containing an anaesthetic steroid - Google Patents

Anaesthetic compositions containing an anaesthetic steroid

Info

Publication number
CA1001073A
CA1001073A CA085,973A CA85973A CA1001073A CA 1001073 A CA1001073 A CA 1001073A CA 85973 A CA85973 A CA 85973A CA 1001073 A CA1001073 A CA 1001073A
Authority
CA
Canada
Prior art keywords
anaesthetic
steroid
compositions containing
anaesthetic compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA085,973A
Other languages
English (en)
Inventor
Benjamin Davis
Gordon H. Phillipps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to CA217,940A priority Critical patent/CA1037026A/en
Application granted granted Critical
Publication of CA1001073A publication Critical patent/CA1001073A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA085,973A 1969-06-20 1970-06-19 Anaesthetic compositions containing an anaesthetic steroid Expired CA1001073A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA217,940A CA1037026A (en) 1969-06-20 1975-01-15 Pharmaceutical preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3137169 1969-06-20

Publications (1)

Publication Number Publication Date
CA1001073A true CA1001073A (en) 1976-12-07

Family

ID=10322106

Family Applications (1)

Application Number Title Priority Date Filing Date
CA085,973A Expired CA1001073A (en) 1969-06-20 1970-06-19 Anaesthetic compositions containing an anaesthetic steroid

Country Status (19)

Country Link
US (2) US3714352A (es)
JP (1) JPS5140135B1 (es)
AT (2) AT315375B (es)
BE (1) BE752165A (es)
BR (1) BR6915173D0 (es)
CA (1) CA1001073A (es)
CH (1) CH578016A5 (es)
DE (3) DE2030402B2 (es)
DK (1) DK129390B (es)
ES (1) ES380943A1 (es)
FR (2) FR2052999B1 (es)
GB (1) GB1317184A (es)
IE (1) IE35203B1 (es)
IL (1) IL34713A (es)
NL (1) NL169480C (es)
NO (1) NO133716C (es)
PH (1) PH11156A (es)
SE (2) SE406038B (es)
ZA (1) ZA703861B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1376892A (en) * 1970-11-12 1974-12-11 Glaxo Lab Ltd 2beta-substituted-3alpha-hydroxysteroids and their esters
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
GB1377609A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy-5alpha-pregnane compounds
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
GB1430932A (en) * 1972-05-05 1976-04-07 Glaxo Lab Ltd 21-fluoro-pregnanes
GB1436324A (en) * 1972-05-12 1976-05-19 Glaxo Lab Ltd Anaesthetic 3alpha-hydroxy pregnanes
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
IT1204778B (it) 1986-02-04 1989-03-10 Mazzarella Basilio Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
IE920759A1 (en) * 1991-03-29 1992-10-07 Generali Costruzioni Srl Standardized step module for building prefabricated¹staircases, process for producing such module, prefabricated¹staircase and process for assembling prefabricated¹staircases
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
JPWO2005089716A1 (ja) * 2004-03-24 2008-01-31 武田薬品工業株式会社 高含量化製剤
CN112384525A (zh) 2018-07-03 2021-02-19 德劳布里奇制药有限公司 神经活性类固醇及制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1281205A (fr) * 1956-12-21 1962-01-12 Organon Nv Procédé d'obtention de composés de la série du prégnane

Also Published As

Publication number Publication date
BE752165A (fr) 1970-12-18
ZA703861B (en) 1971-02-24
FR2052999A1 (es) 1971-04-16
JPS5140135B1 (es) 1976-11-01
DK129390C (es) 1975-02-24
NL7009002A (es) 1970-12-22
NL169480B (nl) 1982-02-16
FR2052998B1 (es) 1974-08-30
NO133716B (es) 1976-03-08
FR2052998A1 (es) 1971-04-16
AT315375B (de) 1974-05-27
PH11156A (en) 1977-10-28
CH578016A5 (es) 1976-07-30
NL169480C (nl) 1982-07-16
SE401512B (sv) 1978-05-16
DK129390B (da) 1974-10-07
IL34713A0 (en) 1970-08-19
IE35203B1 (en) 1975-12-10
ATA710872A (de) 1975-03-15
GB1317184A (en) 1973-05-16
US3781435A (en) 1973-12-25
BR6915173D0 (pt) 1973-02-08
IL34713A (en) 1975-06-25
FR2052999B1 (es) 1974-06-14
NO133716C (es) 1976-06-16
DE2030402C3 (es) 1975-12-11
AT326826B (de) 1975-12-29
DE2030402B2 (de) 1975-04-30
IE35203L (en) 1970-12-20
DE2065332A1 (de) 1973-04-05
SE406038B (sv) 1979-01-22
DE2065513A1 (de) 1974-04-04
DE2030402A1 (de) 1971-01-21
US3714352A (en) 1973-01-30
ES380943A1 (es) 1973-07-01

Similar Documents

Publication Publication Date Title
CA952025A (en) Compositions cosmetiques deodorisantes micro-encapsulees
CA1001073A (en) Anaesthetic compositions containing an anaesthetic steroid
CA967486A (en) Compositions decolorantes utilisables en cosmetique
CA927528A (en) Radiographic compositions
CA970281A (en) Anesthetic composition containing an anesthetic steroid
CA965008A (en) Compositions anti-seborrheiques et antiacneiques
CA967881A (en) Anaesthetic composition containing an anaesthetic steroid
CA934488A (en) Compositions soufrees
CA965010A (en) Compositions antiseborrheiques
AU2085570A (en) Rubber-polyester compositions
AU1211470A (en) Composition
AU3545971A (en) Steroid compositions
CA975682A (en) Anaesthetic compositions containing an anaesthetic steroid
CA820857A (en) Deodorizing compositions
CA830476A (en) Therapeutic compositions containing aminocyclobutanols
CA829334A (en) Steroid analogs
AU1292270A (en) Improved beverage-forming compositions
CA825667A (en) Steroid derivatives compositions
CA824162A (en) Substituted toluidides and compositions containing them
AU453152B2 (en) Self-shining floorcare compositions
CA815578A (en) Polyepoxide-polyester compositions
AU456541B2 (en) Gastropodicidal compositions
AU436058B2 (en) Bolck-copolymer-polypropylene compositions
AU267940B2 (en) Pharmaceutical compositions containing asteroid
AU456939B2 (en) Ester containing composition